STOCK TITAN

RBC Bearings (RBC) VP granted 160 shares and 160 stock options as equity pay

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

RBC Bearings Inc. vice president and secretary John J. Feeney reported compensation-related equity awards and existing option holdings. On May 19, 2026, he received 160 shares of Common Stock at $0.0000 per share and an accompanying grant of 160 options to purchase Common Stock with an exercise price of $565.22 per share. Following these awards, his direct Common Stock holdings total 2,792 shares, including 1,760 shares of restricted stock that vest in tranches between 2026 and 2031. Footnotes show multiple option grants with staggered vesting, including awards over 1,000–1,200 underlying shares per grant at exercise prices ranging from $181.58 to $364.96, with expirations from 2028 through 2032. Most of these options are currently exercisable, with specified portions scheduled to vest over future dates.

Positive

  • None.

Negative

  • None.
Insider Feeney John J.
Role Vice President and Secretary
Type Security Shares Price Value
Grant/Award Option to Purchase Common Stock 160 $0.00 --
Grant/Award Common Stock 160 $0.00 --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase common Stock -- -- --
Holdings After Transaction: Option to Purchase Common Stock — 160 shares (Direct, null); Common Stock — 2,792 shares (Direct, null); Option to Purchase common Stock — 1,000 shares (Direct, null)
Footnotes (1)
  1. Includes 1,760 shares of restricted stock, which vest according to the following schedule; 100 shares that vest on 6/3/2026; 400 shares 1/2 of which vest on 6/3/2026 and 1/2 vest on 6/3/2027; 300 shares 1/3 of which vest on 6/1/2026, 1/3 vest on 6/1/2027 and 1/3 vest on 6/1/2028; 400 shares 1/4 of which vest on 5/23/2026, 1/4 vest on 5/23/2027, 1/4 vest on 5/23/2028 and 1/4 vest on 5/23/2029; 400 shares 1/5 or which vest on 5/28/2026, 1/5 vest on 5/28/2027, 1/5 vest on 5/28/2028, 1/5 vest on 5/28/2029 and 1/5 vest on 5/28/2030; and 160 shares 1/5 or which vest on 5/19/2027, 1/5 vest on 5/19/2028, 1/5 vest on 5/19/2029, 1/5 vest on 5/19/2030 and 1/5 vest on 5/19/2031. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/19/2027, 1/5 vest on 5/19/2028, 1/5 vest on 5/19/2029, 1/5 vest on 5/19/2030 and 1/5 vest on 5/19/2031. All these options to purchase Common Stock are exerciseable except for 400 options that vest on 6/3/2026. All these options to purchase Common Stock are exerciseable except for 800 options that are subject to the following vesting schedule - 1/2 vest on 6/3/2026 and 1/2 vest on 6/3/2027. All these options to purchase Common Stock are exerciseable except for 600 options that are subject to the following vesting schedule - 1/3 vest on 6/1/2026, 1/3 vest on 6/1/2027 and 1/3 vest on 6/1/2028. All these options to purchase Common Stock are exerciseable except for 800 options that are subject to the following vesting schedule - 1/4 vest on 5/23/2026, 1/4 vest on 5/23/2027, 1/4 vest on 5/23/2028 and 1/4 vest on 5/23/2029. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/28/2026, 1/5 vest on 5/28/2027, 1/5 vest on 5/28/2028, 1/5 vest on 5/28/2029 and 1/5 vest on 5/28/2030.
Common shares granted 160 shares Grant of Common Stock on May 19, 2026 at $0.0000 per share
Options granted 160 options New option grant on May 19, 2026 over 160 underlying shares
New option exercise price $565.22 per share Exercise price for 160 newly granted options expiring May 27, 2033
Shares held after grant 2,792 shares Total direct Common Stock holdings following May 19, 2026 transactions
Restricted stock within holdings 1,760 shares Restricted shares vesting in tranches from 2026 through 2031
Option position at $364.96 1,000 underlying shares Option award with $364.96 exercise price expiring May 28, 2032
Largest option grant disclosed 1,200 underlying shares Option to purchase Common Stock at $199.10 expiring June 3, 2029
Lowest option exercise price $181.58 per share Option grant over 112 underlying shares expiring February 8, 2028
restricted stock financial
"Includes 1,760 shares of restricted stock, which vest according to the following schedule"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
vesting schedule financial
"These options to purchase Common Stock are subject to the following vesting schedule"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
Option to Purchase Common Stock financial
"These options to purchase Common Stock are subject to the following vesting schedule"
exercise price financial
"exercisePrice: "364.9600""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expirationDate: "2032-05-28T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Feeney John J.

(Last)(First)(Middle)
ONE TRIBOLOGY CENTER
102 WILLENBROCK ROAD

(Street)
OXFORD CONNECTICUT 06478

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RBC Bearings INC [ RBC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Vice President and Secretary
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/19/2026A160A$02,792(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Common Stock$565.2205/19/2026A16005/19/2027(2)05/27/2033Common Stock160$0160D
Option to Purchase Common Stock$181.5802/08/202502/08/2028Common Stock112112D
Option to Purchase Common Stock$199.1606/03/2025(3)06/03/2028Common Stock800800D
Option to Purchase Common Stock$199.106/03/2025(4)06/03/2029Common Stock1,2001,200D
Option to Purchase common Stock$199.5106/01/2024(5)06/01/2030Common Stock1,0001,000D
Option to Purchase Common Stock$292.8505/23/2025(6)05/23/2031Common Stock1,0001,000D
Option to Purchase common Stock$364.9605/28/2026(7)05/28/2032Common Stock1,0001,000D
Explanation of Responses:
1. Includes 1,760 shares of restricted stock, which vest according to the following schedule; 100 shares that vest on 6/3/2026; 400 shares 1/2 of which vest on 6/3/2026 and 1/2 vest on 6/3/2027; 300 shares 1/3 of which vest on 6/1/2026, 1/3 vest on 6/1/2027 and 1/3 vest on 6/1/2028; 400 shares 1/4 of which vest on 5/23/2026, 1/4 vest on 5/23/2027, 1/4 vest on 5/23/2028 and 1/4 vest on 5/23/2029; 400 shares 1/5 or which vest on 5/28/2026, 1/5 vest on 5/28/2027, 1/5 vest on 5/28/2028, 1/5 vest on 5/28/2029 and 1/5 vest on 5/28/2030; and 160 shares 1/5 or which vest on 5/19/2027, 1/5 vest on 5/19/2028, 1/5 vest on 5/19/2029, 1/5 vest on 5/19/2030 and 1/5 vest on 5/19/2031.
2. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/19/2027, 1/5 vest on 5/19/2028, 1/5 vest on 5/19/2029, 1/5 vest on 5/19/2030 and 1/5 vest on 5/19/2031.
3. All these options to purchase Common Stock are exerciseable except for 400 options that vest on 6/3/2026.
4. All these options to purchase Common Stock are exerciseable except for 800 options that are subject to the following vesting schedule - 1/2 vest on 6/3/2026 and 1/2 vest on 6/3/2027.
5. All these options to purchase Common Stock are exerciseable except for 600 options that are subject to the following vesting schedule - 1/3 vest on 6/1/2026, 1/3 vest on 6/1/2027 and 1/3 vest on 6/1/2028.
6. All these options to purchase Common Stock are exerciseable except for 800 options that are subject to the following vesting schedule - 1/4 vest on 5/23/2026, 1/4 vest on 5/23/2027, 1/4 vest on 5/23/2028 and 1/4 vest on 5/23/2029.
7. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/28/2026, 1/5 vest on 5/28/2027, 1/5 vest on 5/28/2028, 1/5 vest on 5/28/2029 and 1/5 vest on 5/28/2030.
Remarks:
/s/John J. Feeney05/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did RBC (RBC) report for John J. Feeney?

RBC Bearings reported that John J. Feeney received a grant of 160 shares of Common Stock and 160 stock options on May 19, 2026. These awards were recorded at $0.0000 per share for the stock and a $565.22 exercise price for the options.

How many RBC (RBC) shares does John J. Feeney hold after this Form 4?

After the reported transactions, John J. Feeney holds 2,792 shares of RBC Bearings Common Stock directly. This total includes 1,760 shares of restricted stock that will vest over several dates between 2026 and 2031, as detailed in the footnote vesting schedules.

What new stock options did John J. Feeney receive from RBC (RBC)?

He received 160 options to purchase RBC Bearings Common Stock with an exercise price of $565.22 per share. These options relate to 160 underlying shares, vest in five equal annual installments starting May 19, 2027, and expire on May 27, 2033, according to the filing.

What existing option grants are disclosed for John J. Feeney at RBC (RBC)?

The filing lists several existing option grants over 112 to 1,200 underlying shares each, with exercise prices between $181.58 and $364.96. Expiration dates range from June 1, 2028 to May 28, 2032, and most options are exercisable except specified tranches still vesting.

How do RBC (RBC) restricted stock awards to John J. Feeney vest?

Feeney’s 1,760 restricted shares vest in multiple schedules, such as 100 shares on June 3, 2026 and 400 shares in fifths from May 28, 2026 through May 28, 2030. Additional blocks vest annually through 2029 and 2031, creating a long-term incentive structure.

Are the reported RBC (RBC) transactions open-market purchases or compensation grants?

The Form 4 characterizes the May 19, 2026 transactions as grants or awards, not open-market purchases. Code “A” indicates grant, award, or other acquisition, with a price of $0.0000 per share, consistent with equity compensation rather than buying shares in the market.